Article
FDA approves ISTA product, asked to evaluate another
On May 6 the FDA approved ISTA Pharmaceutical's new drug application (NDA) for lyophilized, ovine hyaluronidase for injection (Vitrase) for use as a spreading agent to facilitate the dispersion and absorption of other drugs.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
